Oncotargets and Therapy Dovepress the Role of Mir-29b in Cancer: Regulation, Function, and Signaling

MicroRNAs (miRNAs) are endogenous small non-coding RNAs with the capacity to regulate gene expression post-transcriptionally. The miRNA-29 family consists of miR-29a, miR-29b, and miR-29c, among which miR-29b is the most highly expressed and is found at two genomic loci. Recently, numerous studies have demonstrated that aberrant expression of miR-29b is common in the majority of human cancers. miR-29b is known to critically affect cancer progression by functioning as a tumor suppressor. However, it may also act as an oncogene under certain conditions. In this review, we illustrate the role of miR-29b in cancer regulation, function, and signaling. This is the first review highlighting the role of miR-29b in cancer. Our review aims to summarize the effects of miR-29b on cancer activity and its interactions with target genes and signaling pathways, as well as to provide therapeutic implications for overcoming cancer chemoresistance.

[1]  S. Sultana,et al.  Involvement of epigenetics and microRNA-29b in the urethane induced inception and establishment of mouse lung tumors. , 2014, Experimental and molecular pathology.

[2]  Feng Xu,et al.  Effect of miR-29b-1* and miR-29c knockdown on cell growth of the bladder cancer cell line T24 , 2013, The Journal of international medical research.

[3]  M. Caligiuri,et al.  Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human disease. , 2013, Blood.

[4]  furong dai,et al.  The anti-chemoresistant effect and mechanism of MUC1 aptamer-miR-29b chimera in ovarian cancer. , 2013, Gynecologic oncology.

[5]  Ye Ding,et al.  An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis. , 2013, Cell reports.

[6]  Y. Murawaki,et al.  miR-29b, miR-205 and miR-221 Enhance Chemosensitivity to Gemcitabine in HuH28 Human Cholangiocarcinoma Cells , 2013, PloS one.

[7]  J. Martinez-Climent,et al.  Involvement of miRNAs in the Differentiation of Human Glioblastoma Multiforme Stem-Like Cells , 2013, PloS one.

[8]  A. Schetter,et al.  A Key Role of microRNA-29b for the Suppression of Colon Cancer Cell Migration by American Ginseng , 2013, PloS one.

[9]  Y. Okamoto,et al.  Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin–integrin signalling in head and neck squamous cell carcinoma , 2013, British Journal of Cancer.

[10]  Fang Wang,et al.  The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia , 2013, Cell Death and Differentiation.

[11]  P. Tassone,et al.  miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells , 2013, Cell cycle.

[12]  Junjie Wu,et al.  Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer. , 2013, Biochemical and biophysical research communications.

[13]  T. Ochiya,et al.  miR-29 Represses the Activities of DNA Methyltransferases and DNA Demethylases , 2013, International journal of molecular sciences.

[14]  P. Tassone,et al.  miR‐29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma‐related bone disease , 2013, Journal of cellular physiology.

[15]  C. Croce,et al.  Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression , 2013, Proceedings of the National Academy of Sciences.

[16]  B. Jacobsen,et al.  Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4 , 2013, Oncogene.

[17]  M. Caligiuri,et al.  Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia , 2013, Leukemia.

[18]  L. J. Lee,et al.  Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer , 2013, Molecular therapy. Nucleic acids.

[19]  M. Caligiuri,et al.  Targeted Delivery of microRNA-29b by Transferrin-Conjugated Anionic Lipopolyplex Nanoparticles: A Novel Therapeutic Strategy in Acute Myeloid Leukemia , 2013, Clinical Cancer Research.

[20]  R. Kalluri,et al.  miR-29b moulds the tumour microenvironment to repress metastasis , 2013, Nature Cell Biology.

[21]  David P. Bartel,et al.  Beyond Secondary Structure: Primary-Sequence Determinants License Pri-miRNA Hairpins for Processing , 2013, Cell.

[22]  Z. Werb,et al.  GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression , 2013, Nature Cell Biology.

[23]  Anke Wienecke-Baldacchino,et al.  Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells , 2012, Cell Communication and Signaling.

[24]  Laura A. Sullivan,et al.  Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation. , 2012, Cancer cell.

[25]  N. Munshi,et al.  miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1 , 2012, Cell Death and Disease.

[26]  M. Negrini,et al.  DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma , 2012, Oncotarget.

[27]  M. Tschan,et al.  MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma , 2012, Oncogene.

[28]  Chen Wang,et al.  A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7 , 2012, Journal of Cancer Research and Clinical Oncology.

[29]  M. Caligiuri,et al.  Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia. , 2012, Blood.

[30]  Wei Chen,et al.  Identifying MicroRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis , 2012, BMC Systems Biology.

[31]  B. Torbett,et al.  Transcriptional regulation of MIR29B by PU.1 (SPI1) and MYC during neutrophil differentiation of acute promyelocytic leukaemia cells , 2012, British journal of haematology.

[32]  Peng Ru,et al.  miRNA-29b Suppresses Prostate Cancer Metastasis by Regulating Epithelial–Mesenchymal Transition Signaling , 2012, Molecular Cancer Therapeutics.

[33]  Jian Liang,et al.  The mechanism involved in the loss of PTEN expression in NSCLC tumor cells. , 2012, Biochemical and biophysical research communications.

[34]  V. Puduvalli,et al.  Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia. , 2012, Blood.

[35]  Yuefeng Yang,et al.  Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1. , 2011, Biochemical and biophysical research communications.

[36]  Junping Zhang,et al.  Upregulated MicroRNA-29a by Hepatitis B Virus X Protein Enhances Hepatoma Cell Migration by Targeting PTEN in Cell Culture Model , 2011, PloS one.

[37]  R. Turner,et al.  Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma , 2011, Epigenetics.

[38]  Zhen Bian,et al.  miR-29b regulates migration of human breast cancer cells , 2011, Molecular and Cellular Biochemistry.

[39]  P. Kantharidis,et al.  TGF-β Regulates miR-206 and miR-29 to Control Myogenic Differentiation through Regulation of HDAC4 , 2011, The Journal of Biological Chemistry.

[40]  S. Hammond,et al.  miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis. , 2011, Genes & development.

[41]  J. Steitz,et al.  miR-29 and miR-30 regulate B-Myb expression during cellular senescence , 2010, Proceedings of the National Academy of Sciences.

[42]  Wei Zhang,et al.  miR‐29b and miR‐125a regulate podoplanin and suppress invasion in glioblastoma , 2010, Genes, chromosomes & cancer.

[43]  S. Bronk,et al.  Transcriptional suppression of mir‐29b‐1/mir‐29a promoter by c‐Myc, hedgehog, and NF‐kappaB , 2010, Journal of cellular biochemistry.

[44]  T. Pabst,et al.  The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML , 2010, British Journal of Cancer.

[45]  Y. Pekarsky,et al.  Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression , 2010, Proceedings of the National Academy of Sciences.

[46]  C. Bloomfield,et al.  Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine , 2010, Proceedings of the National Academy of Sciences.

[47]  R. Ray,et al.  MBP-1 upregulates miR-29b that represses Mcl-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells. , 2010, Genes & cancer.

[48]  I. Weissman,et al.  microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia , 2010, The Journal of experimental medicine.

[49]  C. Croce,et al.  MicroRNA 29b functions in acute myeloid leukemia. , 2009, Blood.

[50]  D. Epstein,et al.  Role of miR-29b on the regulation of the extracellular matrix in human trabecular meshwork cells under chronic oxidative stress , 2009, Molecular vision.

[51]  J. Yun,et al.  Effects of MicroRNA‐29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma , 2009, Hepatology.

[52]  Hong Xu,et al.  MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. , 2009, Cancer research.

[53]  Xi He,et al.  Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.

[54]  C. Bloomfield,et al.  MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. , 2009, Blood.

[55]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[56]  F. Slack,et al.  MicroRNA in cancer prognosis. , 2008, The New England journal of medicine.

[57]  Huating Wang,et al.  NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. , 2008, Cancer cell.

[58]  C. Tepper,et al.  Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer. , 2008, Cancer research.

[59]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[60]  C. Morrison,et al.  MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.

[61]  G. Gores,et al.  mir-29 regulates Mcl-1 protein expression and apoptosis , 2007, Oncogene.

[62]  W. Filipowicz,et al.  Repression of protein synthesis by miRNAs: how many mechanisms? , 2007, Trends in cell biology.

[63]  Tushar Patel,et al.  Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. , 2006, Gastroenterology.

[64]  Cheng-Ta Yang,et al.  Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines. , 2006, Biochemical and biophysical research communications.

[65]  Chang-Zheng Chen,et al.  MicroRNAs as oncogenes and tumor suppressors. , 2005, The New England journal of medicine.

[66]  W. Sadee,et al.  Growth factor signaling and resistance to cancer chemotherapy. , 2004, Current topics in medicinal chemistry.

[67]  Biao He,et al.  Wnt Inhibitory Factor-1 Is Silenced by Promoter Hypermethylation in Human Lung Cancer , 2004, Cancer Research.

[68]  Tsung-Cheng Chang,et al.  Widespread microRNA repression by Myc contributes to tumorigenesis , 2008, Nature Genetics.

[69]  Y. Pekarsky,et al.  Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. , 2006, Cancer research.